Immediate Impact

1 by Nobel laureates 39 standout
Sub-graph 1 of 20

Citing Papers

Role of SLC7A11/xCT in Ovarian Cancer
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
2 intermediate papers

Works of Tilman Schöning being referenced

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol
2017
Antitumor Effects of Proteasome Inhibition in Anaplastic Thyroid Carcinoma
2012

Author Peers

Author Last Decade Papers Cites
Tilman Schöning 63 11 16 36 35 9 130
Cristian Serna‐Tamayo 79 6 3 36 53 7 195
Siti Mardhiana Mohamad 50 5 18 32 29 7 183
María Isabel Gaillard 30 7 12 19 45 12 195
Thomas S. Watkins 91 4 31 40 21 10 215
Patrizia Palomba 47 11 32 40 19 15 166
Stefano Di Cecca 55 6 16 64 51 13 217
Mark Stow 37 4 16 88 14 8 164
Anna‐Sophia Wiekmeijer 54 8 22 65 28 11 184
Wenjun Cai 18 7 3 76 14 9 156
Coralie Briand 33 3 43 28 17 9 153

All Works

Loading papers...

Rankless by CCL
2026